<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Central <z:mp ids='MP_0008912'>nervous</z:mp> system damage in <z:mp ids='MP_0002055'>diabetes</z:mp> is caused by both cerebral <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> and the detrimental effect of <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0020456" disease_type="Disease or Syndrome" abbrv="">hyperglycaemia</z:e> on <z:mp ids='MP_0008912'>nervous</z:mp> tissue </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="C0020456" disease_type="Disease or Syndrome" abbrv="">Hyperglycaemia</z:e> is the primer of a series of cascade reactions causing overproduction of free radicals </plain></SENT>
<SENT sid="2" pm="."><plain>There is increasing evidence that these reactive molecules contribute to neuronal tissue damage </plain></SENT>
<SENT sid="3" pm="."><plain>Dehydroepiandrosterone (DHEA) has been reported to possess <z:chebi fb="11" ids="22586">antioxidant</z:chebi> properties </plain></SENT>
<SENT sid="4" pm="."><plain>This study evaluates the oxidative status in the synaptosomal fraction isolated from the brain of <z:chebi fb="1" ids="9288">streptozotocin</z:chebi>-treated rats and the <z:chebi fb="11" ids="22586">antioxidant</z:chebi> effect of DHEA treatment on diabetic rats </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="1" ids="29191">Hydroxyl radical</z:chebi> generation, <z:chebi fb="17" ids="16240">hydrogen peroxide</z:chebi> content, and the level of the reactive oxygen species was increased (P&lt;0.05) in synaptosomes isolated from <z:chebi fb="1" ids="9288">streptozotocin</z:chebi>-treated rats </plain></SENT>
<SENT sid="6" pm="."><plain>The derangement of the oxidative status was confirmed by a low level of reduced <z:chebi fb="0" ids="16856">glutathione</z:chebi> and <z:chebi fb="0" ids="22470">alpha-tocopherol</z:chebi> </plain></SENT>
<SENT sid="7" pm="."><plain>DHEA treatment (4 mg per day for 3 weeks, per os) protected the synaptosomes against oxidative damage: synaptosomes from diabetic DHEA-treated rats showed a significant decrease in reactive species (P&lt;0.05) and in the formation of end products of <z:chebi fb="23" ids="18059">lipid</z:chebi> peroxidation, evaluated in terms of fluorescent chromolipid (P&lt;0.01) </plain></SENT>
<SENT sid="8" pm="."><plain>Moreover, DHEA treatment restored the <z:chebi fb="2" ids="27208">unsaturated fatty acid</z:chebi> content of the membrane and the reduced <z:chebi fb="0" ids="16856">glutathione</z:chebi> and <z:chebi fb="0" ids="22470">alpha-tocopherol</z:chebi> levels to <z:mpath ids='MPATH_458'>normal</z:mpath> levels and restored membrane NaK-ATPase activity close to control levels </plain></SENT>
<SENT sid="9" pm="."><plain>The results demonstrate that DHEA supplementation greatly reduces oxidative damage in synaptosomes isolated from diabetic rats and suggest that this neurosteroid may participate in protecting the integrity of synaptic membranes against <z:e sem="disease" ids="C0020456" disease_type="Disease or Syndrome" abbrv="">hyperglycaemia</z:e>-induced damage </plain></SENT>
</text></document>